Pharmacy Medical News about Tourette Syndrome Cannabinoids

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cannabinoids for Tourette's Syndrome
Cochrane Reviews, 10/22/09

Curtis A et al. – Only two trials were found that met the inclusion criteria. Both compared a cannabinoid, delta–9–Tetrahydrocannabinol (delta9THC), either as monotherapy or as adjuvant therapy, with placebo. One was a double blind, single dose crossover trial and the other was a double blind, parallel group study. A total of 28 different patients were studied. Although both trials reported a positive effect from delta9THC, the improvements in tic frequency and severity were small and were only detected by some of the outcome measures. Not enough evidence to support the use of cannabinoids in treating tics and obsessive compulsive behaviour in people with Tourette's syndrome.

<< Previous
S-Adenosylmethionine for osteoarthritis of the knee or hip

Next >>
Experience with injectable long-acting risperidone in long-term...